Narciclasine as a potential therapeutic agent to overcome EGFR-TKI resistance in non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Sung JY 

PROVIDER: S-EPMC12679757 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature